CD8+ T-Cell Tolerance can be Broken by an Adenoviral Vaccine While CD4+ T-Cell Tolerance is Broken by Additional Co-administration of a Toll-Like Receptor Ligand
about
Inhibition and promotion of tumor growth with adeno-associated virus carcinoembryonic antigen vaccine and Toll-like receptor agonists.Tumor immunotherapy using adenovirus vaccines in combination with intratumoral doses of CpG ODNAdenovirus vaccine immunotherapy targeting WT1-expressing tumors.Cancer immunotherapy.
P2860
CD8+ T-Cell Tolerance can be Broken by an Adenoviral Vaccine While CD4+ T-Cell Tolerance is Broken by Additional Co-administration of a Toll-Like Receptor Ligand
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2006
@uk
name
CD8+ T-Cell Tolerance can be B ...... of a Toll-Like Receptor Ligand
@en
CD8+ T-Cell Tolerance can be B ...... of a Toll-Like Receptor Ligand
@nl
type
label
CD8+ T-Cell Tolerance can be B ...... of a Toll-Like Receptor Ligand
@en
CD8+ T-Cell Tolerance can be B ...... of a Toll-Like Receptor Ligand
@nl
prefLabel
CD8+ T-Cell Tolerance can be B ...... of a Toll-Like Receptor Ligand
@en
CD8+ T-Cell Tolerance can be B ...... of a Toll-Like Receptor Ligand
@nl
P2093
P2860
P1476
CD8+ T-Cell Tolerance can be B ...... of a Toll-Like Receptor Ligand
@en
P2093
C. Mennuni
E. Scarselli
F. Calvaruso
G. Ciliberto
N. La Monica
V. Salucci
P2860
P356
10.1111/J.1365-3083.2006.01706.X
P577
2006-01-01T00:00:00Z